Search

Your search keyword '"Rino, Y"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Rino, Y" Remove constraint Author: "Rino, Y" Journal in vivo athens greece Remove constraint Journal: in vivo athens greece
53 results on '"Rino, Y"'

Search Results

1. The Clinical Impact of the Pretreatment Albumin to Fibrinogen Ratio in Esophageal Cancer Patients Who Receive Curative Treatment.

2. Survival Predictors Before Preoperative Adjuvant Chemotherapy in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma.

3. Albumin-Globulin Ratio Is an Independent Prognostic Factor for Gastric Cancer Patients who Received Curative Treatment.

4. Clinical Impact of the C-reactive Protein-albumin-lymphocyte Index in Post-gastrectomy Patients With Gastric Cancer.

5. The Naples Prognostic Score Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.

6. The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric Cancer.

7. Effect of Preoperative Gastric Shape on Loss of Lean Body Mass After Distal Gastrectomy.

8. Significance of Preoperative Modified Nutritional Risk Index in Patients With Gastric Cancer After Curative Resection.

9. Clinical Significance of Prealbumin Level Measurement Before Neoadjuvant Chemotherapy in Elderly Patients With Locally Advanced Esophageal Cancer.

10. The Clinical Impact of the Pretreatment Platelet-to-Lymphocyte Ratio in Gastric Cancer Patients Who Receive Curative Treatment.

11. Influence of the Oral Health Assessment Tool Score on Survival of Patients With Esophageal Cancer.

12. Can Clinical Stage in the 8 th Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction?

13. Does Intestinal Peristalsis Cause Suture Failure After Instrument Suture?

14. Adverse Events in Patients With Esophageal Cancer Treated With Nivolumab in Combination With Radiotherapy.

15. Prognostic Nutritional Index as a Predictor of Prognosis in Postoperative Patients With Gastric Cancer.

16. The Clinical Impact of Synchronous and Metachronous Other Primary Cancer in Gastric Cancer Patients Who Receive Curative Treatment.

17. Clinical Significance of Mean Corpuscular Volume in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma.

18. The Platelet-to-Lymphocyte Ratio Is an Independent Prognostic Factor for Patients With Esophageal Cancer Who Receive Curative Treatment.

19. Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment.

20. Clinical Impact of Preoperative Albumin-Bilirubin Status in Esophageal Cancer Patients Who Receive Curative Treatment.

21. The Clinical Influence of the CONUT Score on Survival of Patients With Gastric Cancer Receiving Curative Treatment.

22. Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.

23. The Association of the Lymphocyte-to-C-Reactive-Protein Ratio With Gastric Cancer Patients Who Receive Curative Treatment.

24. Low Preoperative Albumin-to-Globulin Ratio Is a Marker of Poor Prognosis in Patients With Esophageal Cancer.

25. The Clinical Influence of the C-Reactive Protein-to-Albumin Ratio in Patients Who Received Curative Treatment for Gastric Cancer.

26. Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Colorectal Cancer: A Multicenter Retrospective Study.

27. Clinical Significance of TAP1 and DLL4 Expression in Patients With Locally Advanced Gastric Cancer.

28. A Gender Comparison of Bone Metabolic Changes After Gastric Cancer Surgery: A Prospective Observational Study.

29. Comparison of the Dietary Intake Loss Between Total and Distal Gastrectomy for Gastric Cancer.

30. Effect of Prognostic Nutrition Index in Gastric or Gastro-oesophageal Junction Cancer Patients Undergoing Nivolumab Monotherapy.

31. Rectal Cancer Surgery in Patients Older Than 80 Years: Is Hartmann's Procedure Safe?

32. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.

33. A Comparison of Open and Laparoscopic-assisted Colectomy for Obstructive Colon Cancer.

34. Laparoscopic Total Gastrectomy for Gastric Cancer in Elderly Patients.

35. The Short- and Long-term Outcomes of Gastrectomy in Elderly Patients With Gastric Cancer.

36. The Number of Harvested LNs Is an Independent Prognostic Factor in Lymph Node Metastasis-negative Patients Who Received Curative Esophagectomy.

37. Laparoscopic vs. Open Surgery for Stage II/III Colon Cancer Patients With Body Mass Index >25 kg/m 2 .

38. The Lymph Node Ratio Is an Independent Prognostic Factor in Esophageal Cancer Patients Who Receive Curative Surgery.

39. The Impact of Intraoperative Blood Loss on the Survival of Patients With Stage II/III Pancreatic Cancer.

40. The Clinical Significance of Lymphovascular Invasion in Gastric Cancer.

41. Risk Factors for Postoperative Anastomosis Leak After Esophagectomy for Esophageal Cancer.

42. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.

43. Clinical Implication of Pre-operative C-reactive Protein-Albumin Ratio as a Prognostic Factor of Patients With Pancreatic Ductal Adenocarcinoma: A Single-institutional Retrospective Study.

44. Impact of the ESM-1 Gene Expression on Outcomes in Stage II/III Gastric Cancer Patients Who Received Adjuvant S-1 Chemotherapy.

45. Additional Surgical Resection After Endoscopic Resection for Patients With High-risk T1 Colorectal Cancer.

46. Beppu's Nomogram Score Is an Independent Prognostic Factor for Colorectal Liver Metastasis Receiving Perioperative Chemotherapy and/or Targeted Therapy.

47. Postoperative Level of C-Reactive Protein Is a Prognosticator After Esophageal Cancer Surgery With Perioperative Steroid Therapy and Enhanced Recovery After Surgery Care.

48. Comparison of Weight and Body Composition After Gastrectomy Between Elderly and Non-elderly Patients With Gastric Cancer.

49. A Comparison of the Body Composition Changes Between Laparoscopy-assisted and Open Total Gastrectomy for Gastric Cancer.

50. EZH2 Overexpression as a Useful Prognostic Marker for Aggressive Behaviour in Thyroid Cancer.

Catalog

Books, media, physical & digital resources